Amgen (AMGN) Net Margin (2016 - 2025)
Historic Net Margin for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to 33.65%.
- Amgen's Net Margin rose 3700.0% to 33.65% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.47%, marking a year-over-year increase of 64700.0%. This contributed to the annual value of 12.24% for FY2024, which is 115900.0% down from last year.
- According to the latest figures from Q3 2025, Amgen's Net Margin is 33.65%, which was up 3700.0% from 15.6% recorded in Q2 2025.
- In the past 5 years, Amgen's Net Margin registered a high of 46.54% during Q1 2023, and its lowest value of 1.52% during Q1 2024.
- Moreover, its 5-year median value for Net Margin was 23.63% (2022), whereas its average is 21.53%.
- Per our database at Business Quant, Amgen's Net Margin soared by 228700bps in 2023 and then plummeted by -480500bps in 2024.
- Over the past 5 years, Amgen's Net Margin (Quarter) stood at 27.74% in 2021, then decreased by -15bps to 23.63% in 2022, then plummeted by -60bps to 9.36% in 2023, then decreased by -26bps to 6.9% in 2024, then soared by 388bps to 33.65% in 2025.
- Its last three reported values are 33.65% in Q3 2025, 15.6% for Q2 2025, and 21.23% during Q1 2025.